CAH Panel 3 (Aldosterone Synthase Deficiency)
Test Code
15273
82088, 82528, 82634, 83498
Clinical Significance
CAH Panel 3 (Aldosterone Synthase Deficiency) -
This panel may be used for differential diagnosis of congenital adrenal hyperplasia (CAH) and aldosterone synthase deficiency. In addition to the analytes included in this panel (17-hydroxyprogesterone, 11-deoxycortisol, 18-hydroxycorticosterone, aldosterone), other tests may be required to establish a diagnosis.
CAH is a group of autosomal recessive diseases characterized by deficiencies of enzymes in steroid hormone production. These deficiencies cause imbalances of steroid intermediates and hormones. Clinical manifestations of CAH vary and depend upon the type of defect [1,2]. When ...
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
17-Hydroxyprogesterone
11-Deoxycortisol
18-Hydroxycorticosterone
Aldosterone, LC/MS
11-Deoxycortisol
18-Hydroxycorticosterone
Aldosterone, LC/MS
Methodology
See individual tests
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
See Laboratory Report